Check Before You Invest : Pharmaids Pharmaceuticals Ltd

Snapshot

Q.1 Which industry/sub-sector does Pharmaids Pharmaceuticals Ltd belong to?

Pharmaids Pharmaceuticals Ltd belongs to the Healthcare sector, operating specifically within the Pharmaceuticals & Drugs segment.

Q.2 Is Pharmaids Pharmaceuticals Ltd a good quality company?

Pharmaids Pharmaceuticals Ltd is a weak quality company, based on a inconsistent 8-year financial track record.

Q.3 Is Pharmaids Pharmaceuticals Ltd undervalued or overvalued?

Pharmaids Pharmaceuticals Ltd appears Fair, as its key valuation ratios are in line with their past averages.

Q.4 Is Pharmaids Pharmaceuticals Ltd a good buy now?

Pharmaids Pharmaceuticals Ltd is not a good buy now, based on weak price trend analysis suggesting prices may fall. However, you need to check its quality and valuation before making a decision

Performance Analysis

Q.1 Revenue growth of Pharmaids Pharmaceuticals Ltd?

Pharmaids Pharmaceuticals Ltd revenue growth is 7,700% for FY-2025, which is below its 5-year CAGR of NA%, indicating slower growth.

Q.2 Return on capital employed (ROCE) of Pharmaids Pharmaceuticals Ltd?

Pharmaids Pharmaceuticals Ltd Return on capital employed is -6.89% for FY-2025, which is in line with its 5-year historical median of -6.89%. The current ROCE is below its estimated weighted average cost of capital (WACC) of 14%, indicating value preservation.

Q.3 Return on Asset of Pharmaids Pharmaceuticals Ltd?

Pharmaids Pharmaceuticals Ltd Return on Asset is -7.48%, which is in line with its 5-year historical median of -7.48%, indicating stable asset utilization efficiency.

Q.4 Return on Equity (ROE) of Pharmaids Pharmaceuticals Ltd?

Pharmaids Pharmaceuticals Ltd Return on equity is -10.8% for FY-2025, which is in line with its 5-year historical median of -10.64%, indicating the business is making similar use of its shareholders capital.

Q.5 Gross Profit margin of Pharmaids Pharmaceuticals Ltd?

Pharmaids Pharmaceuticals Ltd Gross profit margin which is the profit after deduction of direct costs, is -358.3% for FY-2025, which is below its 5-year median of -17.3%, indicating decreasing margins.

Q.6 Operating Profit Margin of Pharmaids Pharmaceuticals Ltd?

Pharmaids Pharmaceuticals Ltd Operating Profit Margin which is the profit after deduction of all operating costs, is -310% for FY-2025, which is below its 5-year median of -18.13% indicating decreasing margins.

Q.7 Net Profit Margin of Pharmaids Pharmaceuticals Ltd?

Pharmaids Pharmaceuticals Ltd Net Profit Margin is -310.96% for FY-2025, is below with its 5-year median of -31.6%, indicating decreasing margins.

	Current Level	5-year Historic Median
Gross Profit Margin	-358.3	-17.3
Operating Profit Margin	-310	-18.13
Net Profit Margin	-310.96	-31.6

Q.8 Debt to Equity ratio of Pharmaids Pharmaceuticals Ltd?

Pharmaids Pharmaceuticals Ltd Debt-to-Equity ratio is 0.62, which is above with the industry average of 0.27, indicating higher debt levels in the industry.

Q.9 Debt to cash flow from operations of Pharmaids Pharmaceuticals Ltd?

Pharmaids Pharmaceuticals Ltd Debt to cash flow from operations is -5.1, which is at a unhealthy level.

Ownership & governance

Q.1 Promoter shareholding and pledge status of Pharmaids Pharmaceuticals Ltd?

Promoters hold 32.99% of the Pharmaids Pharmaceuticals Ltd, with 0.00% of their stake pledged, indicating no pledge risk.

Peer comparison (industry-wise, mcap)

Q.1 Revenue growth of Pharmaids Pharmaceuticals Ltd vs industry peers?

Pharmaids Pharmaceuticals Ltd revenue CAGR is 0.00%, compared to the industry median CAGR of 8.30%, indicating slower growth and losing its market share.

Profit Metrics

	Current Level	5-year Industry Median
Revenue Growth	7	8.3
Gross Profit Growth	0	14.7
Operating Profit Growth	0	11.4
Net Profit Growth	0	NAN

Operating Efficiency

	Current Level	5-year Industry Median
Asset Turnover	0.02	0.81
ROE	-10.8	9.49
ROCE	-6.89	11.91
Cash Conversion Cycle (days)	654.89	85

Valuation & price assessment

Q.1 Stock return of Pharmaids Pharmaceuticals Ltd over the last decade?

Over the last 9 year(s), the stock has delivered a CAGR of 24.7% based on the current price.

Q.2 What return has the stock given over the last decade?

	9Y	5Y	3Y	1Y
Share Price CAGR	24.7%	7.7%	0.6%	-54.6%

Q.3 Valuation ratios of Pharmaids Pharmaceuticals Ltd vs historical?

The current P/E is lower that its historical median.

Q.4 How do the current valuation ratios compare with 5-year historical median and industry numbers?

Valuation Ratios	Current	5-year Historic Median	5-year Industry Median
Price to Earnings	-	113.81	31.09
Price to Book	1.91	2.52	2.85
Price to Sales	13.01	33.89	2.79
EV to EBITDA	-10.11	-12.35	15.87

Check more companies

5. Wockhardt

8. Pfizer

10. Neuland Laboratories

Check trending companies

1. The Federal Bank Ltd.

2. Bajaj Auto Ltd.

3. Cholamandalam Investment and Finance Company Ltd.

4. Aditya Birla Sun Life AMC Ltd.

5. Eicher Motors Ltd.